Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis
Open accessThe DOI matches its Crossref record; 113 of the 114 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Type II focal cortical dysplasia (FCD) is a neuropathological entity characterised by cortical dyslamination with the presence of dysmorphic neurons only (FCDIIA) or the presence of both dysmorphic neurons and balloon cells (FCDIIB). The year 2021 marks the 50th anniversary of the recognition of FCD as a cause of drug resistant epilepsy, and it is now the most common reason for epilepsy surgery. The causes of FCD remained unknown until relatively recently. The study of resected human FCD tissue using novel genomic technologies has led to remarkable advances in understanding the genetic basis of FCD. Mechanistic parallels have emerged between these non-neoplastic lesions and neoplastic disorders of cell growth and differentiation, especially through perturbations of the mammalian target of rapamycin (mTOR) signalling pathway. This narrative review presents the advances through which the aetiology of FCDII has been elucidated in chronological order, from recognition of an association between FCD and the mTOR pathway to the identification of somatic mosaicism within FCD tissue. We discuss the role of a two-hit mechanism, highlight current challenges and future directions in detecting somatic mosaicism in brain and discuss how knowledge of FCD may inform novel precision treatments of these focal epileptogenic malformations of human cortical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Germline LOF variants in proteins that comprise the GATOR1 complex (DEPDC5, NPRL2, NPRL3), responsible for sensing amino acid levels, cause both nonlesional focal epilepsy and epilepsy associated with focal cortical dysplasia (FCD) type II 122 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic mosaicism can be found in brain-derived DNA at low levels on surgical specimens, cerebrospinal fluid or implanted EEG electrodes 122, 177, 178 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [122]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“These downstream phosphorylated substrates, including phosphorylated ribosomal protein S6 (p-S6), are a result of the serine/threonine kinase activity of mTOR [23].”
BackgroundmTOR at the nexus of nutrition, growth, ageing and disease
Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737 · cited 3×
“In the brain, the mTOR pathway also has specific roles during both develop‐ ment and adulthood (reviewed in [20]).”
BackgroundInfluentialMode of cell migration to the superficial layers of fetal monkey neocortex
Rakic, P. (1972) · Journal of Comparative Neurology · doi:10.1002/cne.901450105 · Cited by 2,170 · cited 2×
“During corticogenesis, pyrami‐ al neurons migrate long distances in a radial fashion, from the ventricular zone to the different layers of cortex [96].”
BackgroundA mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Blümcke, I., Thom, M., Aronica, E., Armstrong, D. D., Vinters, H. V., Palmini, A., Jacques, T. S., Avanzini, G., Barkovich, A. J., Battaglia, G., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02777.x · Cited by 1,743 · cited 1×
“The most recent classification established by the International League Against Epilepsy [6] proposed three FCD subtypes: FCD type I (FCDI) exhibits abnormal radial and/or tangential lamination; FCD type II (FCDII) is characterised by abnormal lamination and the presence of an abnormal cell type; and when FCDI co-exist…”
BackgroundVÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648 · cited 1×
“While the genetic causes of FCD remained unclear until relatively recently, early linkage studies attributed TSC to two disease-causing loci located on chromosome 9 and 16 [8,9], and the two genes were eventually identified and termed TSC1 and TSC2 respectively [10,11].”
BackgroundIdentification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Interneuron Migration from Basal Forebrain to Neocortex: Dependence on Dlx Genes
Anderson, S. A., Eisenstat, D. D., Shi, L., & Rubenstein, J. L. R. (1997) · Science · doi:10.1126/science.278.5337.474 · Cited by 1,462 · cited 2×
“In contrast, interneurons originate from ganglio ic emi‐ nence and migrate in a tangential direction before entering the cortex [97].”
Background
Research works printed but not linked: 2
- Horsley, 1886, Brain Surgery, Br. Med. J., 2, 670
- Stephenson, S.E.M., Owens, H.G., Richards, K.L., Lee, W.S., D’Arcy, C., Barton, S., Mandelstam, S.A., Maixner, W.J., MacGregor, D., and Petrou, S. (2019). Dysmorphic neuron density is highest in the centre of epileptogenic cortical tubers. bioRxiv, 621607.
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
“[H2] Cell signalling Several cell signalling pathways have been implicated in epilepsies, with the most prominent being the mechanistic (formerly mammalian) target of rapamycin (mTOR) pathway 122, 123 .”
Anti-seizure gene therapy for focal cortical dysplasia
Almacellas‐Barbanoj, A., Graham, R., Maffei, B., Carpenter, J. C., Leite, M., Hoke, J., Hardjo, F., Scott-Solache, J., Chimonides, C., Schorge, S., et al. (2023) · Brain · doi:10.1093/brain/awad387 · Cited by 44
Brain somatic mosaicism in epilepsy: Bringing results back to the clinic
D’Gama, A. M., & Poduri, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106104 · Cited by 41
Congenital Brain Malformations: An Integrated Diagnostic Approach
Chaudhari, B. P., & Ho, M. (2022) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2022.100973 · Cited by 36
Boff, M. O., Xavier, F. A. C., Diz, F. M., Gonçalves, J. B., Ferreira, L. O., Zambeli, J., Pazzin, D. B., Previato, T. T. R., Erwig, H. S., Gonçalves, J. I. B., et al. (2025) · Cells · doi:10.3390/cells14090662 · Cited by 25
“Hemimegalencephaly (HME) is a malformation that histopathologically resembles FCD [44] and is defined by the presence of anomalous neuronal and glial cells within one hemisphere of the brain [45].”
Spatial omics reveals molecular changes in focal cortical dysplasia type II
Vermeulen, I., Rodriguez-Alvarez, N., François, L., Viot, D., Poosti, F., Aronica, E., Dedeurwaerdere, S., Barton, P., Cillero‐Pastor, B., & Heeren, R. M. A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106491 · Cited by 21
“…models (Bercury et al., 2014; Blumcke et al., 2021; Donkels et al., 2020; Donkels et al., 2017; Elbaz and Popko, 2019; Gruber et al., 2021; Ishii et al., 2019; Lebrun-Julien et al., 2014; Lee et al., 2022; Muhlebner et al., 2012; Muhlebner et al., 2020; Scholl et al., 2017; Shepherd et al., 2013).”
BackgroundInfluentialThe molecular genetics of PI3K/PTEN/AKT/mTOR pathway in the malformations of cortical development
Ma, Q., Chen, G., Li, Y., Guo, Z., & Zhang, X. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.04.041 · Cited by 21
Spatial transcriptomics in focal cortical dysplasia type IIb
Wang, Y., Wang, Y., Guo, L., Shen, C., Fu, Y., Wei, P., Shan, Y., Wu, Q., Piao, Y.-S., & Zhao, G. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01897-7 · Cited by 18
Krochmalnek, E., Accogli, A., St‐Onge, J., Addour-Boudrahem, N., Prakash, G., Kim, S., Brunette‐Clément, T., Alhajaj, G., Mougharbel, L., Bruneau, E., et al. (2023) · Neurology Genetics · doi:10.1212/nxg.0000000000200103 · Cited by 19
Fawcett, J., Davis, S., & Manford, M. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11860-6 · Cited by 13
“They are associated with focal cortical dysplasia and epilepsy [8] as well as non-structural epilepsy, and a two-hit hypothesis, akin to the cancer two-hit hypothesis has been demonstrated with somatic mutations, superimposed on germ-line mutations in those with epilepsy and structural brain abnormality [9].”
BackgroundAltered functional connectivity and network excitability in a model of cortical dysplasia
Aquiles, A., Fiordelisio, T., Luna‐Munguía, H., & Concha, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-38717-2 · Cited by 11
“Notably, disruption of cortical layering is not a requisite for seizure generation, whereas the presence of dysmorphic neurons is 35 .”
Zillich, L., Gasparotto, M., Rossetti, A. C., Fechtner, O., Maillard, C., Hoffrichter, A., Zillich, E., Jabali, A., Marsoner, F., Artioli, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64980-0 · Cited by 14
Neuropathology and epilepsy surgery: 2022 update
Blümcke, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3813 · Cited by 11
Technological and computational approaches to detect somatic mosaicism in epilepsy
Boßelmann, C. M., Leu, C., & Lal, D. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106208 · Cited by 11
“In lesional focal epilepsy caused by focal cortical dysplasia (FCD), low-clonality cell populations appear as irregular dysmorphic neurons (Lee et al., 2022).”
Iourov, I. Y., Gerasimov, A. P., Zelenova, M. A., Ivanova, N. E., Куринная, О. С., Zabrodskaya, Y. M., Ia, D., Barantsevich, E. R., Vasin, K. S., Kolotii, A. D., et al. (2023) · Molecular Cytogenetics · doi:10.1186/s13039-022-00634-w · Cited by 8
Fang, Y., Zhang, Y., Huang, T., Yang, S., Li, Y., & Zhou, L. (2025) · Acta Epileptologica · doi:10.1186/s42494-024-00195-y · Cited by 8
Mazhit, A., Akbay, B., Трофимов, А. Н., Karapina, O., Duysenbi, S., & Tokay, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031175 · Cited by 8
“Mosaic variants leading to hyperactivation of the mTOR pathway also play a central pathogenic role in both focal cortical dysplasia (FCD) and tuberous sclerosis complex (TSC), which are types of MCD strongly associated with treatment-resistant epilepsy [21,22].”
Multi-tensor diffusion abnormalities of gray matter in an animal model of cortical dysplasia
Villaseñor, P. J., Cortés-Servín, D., Pérez-Moriel, A., Aquiles, A., Luna‐Munguía, H., Ramírez-Manzanares, A., Coronado‐Leija, R., Larriva-Sahd, J. A., & Concha, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1124282 · Cited by 7
Pediatric Brain Maturation and Migration Disorders
Barkovich, M. J. (2022) · Diagnostics · doi:10.3390/diagnostics12051123 · Cited by 7
“FCD II are the most well understood in terms of inciting etiology, and appear to be sequela of mTOR/AKT/PI3K pathway dysregulation [31,33].”
BackgroundInfluentialJin-hong, X., Kong, Y., Wang, N., Li, H., Li, Y., Liu, Z., Yang, Y., Yu, X., Liu, H., Ding, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202409774 · Cited by 8
WONOEP appraisal: Genetic insights into early onset epilepsies
Quatraccioni, A., Cases‐Cunillera, S., Balagura, G., Coleman, M., Rossini, L., Mills, J. D., Casillas-Espinosa, P. M., Moshé, S. L., Sankar, R., Baulac, S., et al. (2024) · Epilepsia · doi:10.1111/epi.18124 · Cited by 6
Self-citationColeman, M., Wang, M., Snell, P., Lee, W. S., D’Arcy, C. E., Mignone, C., Pope, K., Gillies, G., Maixner, W. J., Wray, A. C., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf034 · Cited by 6
“…between the PIK3/AKT/mTOR and GATOR1 complex signalling pathways and TSC and FCD type 2 (FCDII; collectively termed ‘mTORopathies’) 11,14,15 and between the Solute Carrier Family 35 Member A2 ( SLC35A2) gene and a more recently-recognized clinical entity, mild malformation of cortical…”
Self-citationDuncan, J. S. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00175-2 · Cited by 5
The role of leucine in the activation of cellular metabolism: a large integrative review
Gebrin, A. S., & Filho, I. J. Z. (2022) · International Journal of Nutrology · doi:10.54448/ijn22s201 · Cited by 6
Aberrant activation of the mTOR signaling pathway in Rasmussen encephalitis
Qiao, J., Tang, C., Xie, M., Gong, M., Fu, C., Cheng, Z., Chen, Z., Mei, A., Bo, Y., Zhao, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-89426-x · Cited by 4
“Abnormal regulation of the mTORC1 signaling pathway has been confirmed to promote the occurrence of epilepsy, as observed in cortical developmental disorders such as focal cortical dysplasia (FCD), tuberous sclerosis complex (TSC), and hemimegalencephaly (HME) 12 .”
Neurodevelopmental disorders: 2023 update
Carriba, P., Lorenzón, N., & Dierssen, M. (2023) · Free Neuropathology · doi:10.17879/freeneuropathology-2023-4701 · Cited by 5
“cortical tubers, which suggests a closely related origin, although they are clearly different neuropathological entities (Taylor et al., 1971; Lee et al., 2022).”
BackgroundZhang, J., Argueta, D., Tong, X., Vinters, H. V., Mathern, G. W., & Cepeda, C. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1486315 · Cited by 3
Identification of Novel Mosaic Variants in Focal Epilepsy-Associated Patients’ Brain Lesions
Garcia, C. A. B., Zubair, M., Santos, M. V., Lee, S. H., Graham, I. D., Stanley, V., George, R. D., Gleeson, J. G., Machado, H. R., & Yang, X. (2025) · Genes · doi:10.3390/genes16040421 · Cited by 3
“This condition is typified by cortical lamination abnormalities, often accompanied by additional pathological changes, such as neoplasms or vascular malformations [30,31].”
Before the first seizure: The developmental imprint of infant epilepsy on neurodevelopment
Milh, M. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.01.725 · Cited by 3
Farahani, N. I., Wong, K. K. L., Allen, G., Minhas, A., Lin, L. D., Nazir, S., & Julian, L. M. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101177 · Cited by 3
“13,14 16–21 We show that TSC2-deficient scNETs display striking hyper-proliferation and tissue malformations that resemble excess cortical folding.”
Castaño-Martín, R., Métais, A., Ciura, S., & Blauwblomme, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1708220 · Cited by 3
Cytomegalic parvalbumin neurons in fetal cases of hemimegalencephaly
Gélot, A., Draia-Nicolau, T., Mathieu, R., Silvagnoli, L., Watrin, F., Cardoso, C., Manent, J., de Chevigny, A., & Represa, A. (2025) · Epilepsia · doi:10.1111/epi.18325 · Cited by 2
Potential of focal cortical dysplasia in migraine pathogenesis
Fila, M., Przysło, Ł., Derwich, M., Pawlowska, E., & Błasiak, J. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae158 · Cited by 1
Wang, N., Wang, L., Yu, Y., Li, G., Cao, C., Xu, R., Jiang, B., Bi, Y., Xie, M., Hu, C., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13040611 · Cited by 1
“6% correspond to different FCD subtypes [18].”
Hoffman, P. B., Svalina, M. N., Flores, C. A., Brzezinski, C. R., Kushner, J. K., Staple, B. L., Franco, S. J., & Alexander, A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.11.532231 · Cited by 2
Emerging Gene-Based Pathways: mTORopathies
Ziobro, J. M., & Dang, L. T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00054-8
Riaño-Carreño, D. M., Cardenas, A. F., Ramírez-Triana, J., Martínez, C. F., Corredor, S. M., Chacón, S. E., Guio, O. Z., Poveda, J. C. P., & González, D. N. (2025) · Epilepsy Research · doi:10.1016/j.eplepsyres.2025.107693
Esserlind, A.-L., Pedersén, A., Abel, F., Hallböök, T., Reilly, C. J., Nilsson, D., Liakina, T., & Bontell, T. O. (2026) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2026.100856
Automated Detection of Structural Brain Lesions from MRI
Adler, S., Ripart, M., Achten, E., Duncan, J. S., & Wagstyl, K. (2026) · Springer eBooks · doi:10.1007/978-3-032-04182-1_6
Donneger, F. (2022) · theses.fr (ABES) · doi:10.70675/753a050cz1c18z423ez94f8zc1e748a6fa26 · Cited by 1
Role of brain somatic mutations in epileptogenic malformations
Sami, L. (2024) · theses.fr (ABES) · doi:10.70675/a5203ae5zaabez4145zb59fzd7cf74e18443
Peng, L., Shi, Y., Zhao, T., Zhu, H., Chen, B., Zhang, W., & Ding, H. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107442
Rosenow, F., & Mann, C. (2026) · Springer eBooks · doi:10.1007/978-3-032-13040-2_10
Quantifying extra‐lesional interhemispheric cortical asymmetry in focal cortical dysplasia type II
Heidari, F., Torkamani‐Azar, M., Tohka, J., & Kälviäinen, R. K. (2026) · Epilepsia Open · doi:10.1002/epi4.70336
“8,9 Epilepsy is now widely recognized as a network disorder that disrupts normal structural and functional brain connectivity.”
Gao, Y., Ji, X., Feng, S., Gao, Y., Li, L., Wang, B., Zhang, X., & Chen, Q. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1963535
“In both the developing and mature brain, mTOR signaling exerts highly context-dependent and functionally diverse effects (Lee et al., 2022).”
Metadata
- Authors
- Lee, W. S., Baldassari, S., Stephenson, S. E. M., Lockhart, P. J., Baulac, S., & Leventer, R. J.
- Affiliations
- The University of Melbourne (AU)
- Centre National de la Recherche Scientifique (FR)
- Royal Children's Hospital (AU)
- Corresponding author
- Baulac, Stéphanie
- Leventer, Richard J.
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-25
- Volume
- 23
- Issue
- 3
- Pages
- 1344
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8835853
- OpenAlex
- W4210390266
- Cited by
- 45
- References
- 114
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 8 · 2023: 13 · 2022: 7
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Medical Research Council
- National Health and Medical Research Council (1161549)
- H2020 European Research Council (682345)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- focal cortical dysplasia type II, mTOR signaling, epileptogenesis, drug-resistant epilepsy, somatic mosaicism, two-hit mechanism, balloon cells, dysmorphic neurons, human brain tissue
- MeSH terms
- Drug Resistant Epilepsy, Brain, Epilepsy, Humans, Mutation, Neurons, Signal Transduction, Malformations of Cortical Development, TOR Serine-Threonine Kinases, Malformations of Cortical Development, Group I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.